ConductScience.org, home

Paper33178203

Localized Interleukin-12 for Cancer Immunotherapy.

Nguyen KG and 6 others. Front Immunol, 2020. Cited by 363 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Localized Interleukin-12 for Cancer Immunotherapy. Papers, record 33178203. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33178203

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Localized Interleukin-12 for Cancer Immunotherapy.
PubMed
Journal
Front Immunol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
363
iCite
Relative citation ratio, by iCite
16.2
iCite
Revised in PubMed
2021-06-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nguyen KGKhue G
2Vrabel MRMaura R
3Mantooth SMSiena M
4Hopkins JJJared J
5Wagner ESEthan S
6Gabaldon TATaylor A
7Zaharoff DADavid A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Genetic TherapyMajor topic
ImmunotherapyMajor topic
Interleukin-12Major topic
NeoplasmsMajor topic
Animals
Drug Carriers
Drug Compounding
Gene Transfer Techniques
Genetic Vectors
Humans
Treatment Outcome
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA172631NCI NIH HHSUnited StatesR01CA172631PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References389

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130080893A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.PLoS Pathog2018https://conductscience.org/library/papers/30080893PubMed
220157604Tumor Therapy Applying Membrane-bound Form of Cytokines.Immune Netw2009https://conductscience.org/library/papers/20157604PubMed
312810649Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.Cancer Res2003https://conductscience.org/library/papers/12810649PubMed
425639194Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma.Int J Cancer2015https://conductscience.org/library/papers/25639194PubMed
516763609Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.Cancer Gene Ther2006https://conductscience.org/library/papers/16763609PubMed
69574551In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.J Immunol1998https://conductscience.org/library/papers/9574551PubMed
723924790Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.J Immunother2013https://conductscience.org/library/papers/23924790PubMed
822781695Oncolytic virotherapy.Nat Biotechnol2012https://conductscience.org/library/papers/22781695PubMed
919051291Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors.Cancer2009https://conductscience.org/library/papers/19051291PubMed
107636204Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.J Immunol1995https://conductscience.org/library/papers/7636204PubMed
1117310381Long-term immunity elicited by antibody-cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.Cancer Immunol Immunother2007https://conductscience.org/library/papers/17310381PubMed
1228679778Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models.Clin Cancer Res2017https://conductscience.org/library/papers/28679778PubMed
1310999765Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.Clin Cancer Res2000https://conductscience.org/library/papers/10999765PubMed
1422549945The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor.Cancer Res2012https://conductscience.org/library/papers/22549945PubMed
1531142602Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma.J Immunol2019https://conductscience.org/library/papers/31142602PubMed
1629123084Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.Nat Commun2017https://conductscience.org/library/papers/29123084PubMed
1721228885The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.Gene Ther2011https://conductscience.org/library/papers/21228885PubMed
1810561265High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.J Clin Oncol1999https://conductscience.org/library/papers/10561265PubMed
1920539064Using poly-N-acetyl glucosamine gel matrix to deliver IL-12 with anti-schistosomasis vaccination.J Infect Dev Ctries2010https://conductscience.org/library/papers/20539064PubMed
209607576Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.Clin Cancer Res1998https://conductscience.org/library/papers/9607576PubMed

See all 389 referencesDownload CSV of references

Cited by266

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 363 citations.

PMIDTitleJournalYearIn PapersSource
42942783Bench-to-Bedside Development of IMNN-001: A Non-Viral IL-12 Gene Therapy for Advanced Ovarian Cancer.Pharmaceutics2026https://conductscience.org/library/papers/42942783PubMed
42850494Small-molecule NFAT signaling inhibitor with dual NFATc1/NFATc2 activity and limited calcineurin catalytic inhibition.Arch Pharm Res2026https://conductscience.org/library/papers/42850494PubMed
42840974In situ vaccination for the treatment of localized cancer and the prevention of metastatic disease.Front Immunol2026https://conductscience.org/library/papers/42840974PubMed
42799424Polymeric Materials in Cancer Immunotherapy: Advances, Challenges, and Future Directions.Polym Sci Technol2026https://conductscience.org/library/papers/42799424PubMed
42771161Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42771161PubMed
42749873Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.Gene Ther2026https://conductscience.org/library/papers/42749873PubMed
42737611αHSA-proIL-12: A Tumor-Conditional IL-12 Prodrug with Reduced Systemic Toxicity and Potent Antitumor Activity.Int J Mol Sci2026https://conductscience.org/library/papers/42737611PubMed
42662452FLASH radiotherapy as an emerging paradigm in radioimmunotherapy: biological rationale, preclinical evidence, and translational roadmap.Front Immunol2026https://conductscience.org/library/papers/42662452PubMed
42653221Immunotherapy for Cancer: Current Advances and Future Directions.Int J Mol Sci2026https://conductscience.org/library/papers/42653221PubMed
42611979Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study.Clin Cancer Res2026https://conductscience.org/library/papers/42611979PubMed
42558941Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42558941PubMed
42536026The Effects of Remote Ischemic Preconditioning on the Inflammatory Cytokine Response to Free Flap Head and Neck Reconstruction: A Randomized Controlled Trial.Microsurgery2026https://conductscience.org/library/papers/42536026PubMed
42460029Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanoma.RSC Pharm2026https://conductscience.org/library/papers/42460029PubMed
42450298Cartilage Oligomeric Matrix Protein (COMP) Correlates with Disease Progression, Selected Immune Checkpoint Molecules and SIGLEC9 in Colorectal Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42450298PubMed
42386999Systemic health impact of cancer-associated extracellular vesicles and particles.Nat Rev Cancer2026https://conductscience.org/library/papers/42386999PubMed
42360103Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies.J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/42360103PubMed
42334072Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort.Int J Cancer2026https://conductscience.org/library/papers/42334072PubMed
42318057Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1.Mol Ther Oncol2026https://conductscience.org/library/papers/42318057PubMed
42302794TIGIT-targeted IL-12 fusion protein engages NK and CD8+ T cells for potent tumor immunotherapy.Cell Rep Med2026https://conductscience.org/library/papers/42302794PubMed
42292488Preliminary evaluation of a DDA cationic liposome-based pulmonary mucosal immunization platform carrying a SARS-CoV-2 spike-derived branched peptide.Front Immunol2026https://conductscience.org/library/papers/42292488PubMed

See all 266 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD464179PubTator's text mininghttps://conductscience.org/library/genes/4179NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-DRB13123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene
IDO13620PubTator's text mininghttps://conductscience.org/library/genes/3620NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNAR13454PubTator's text mininghttps://conductscience.org/library/genes/3454NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL12A3592PubTator's text mininghttps://conductscience.org/library/genes/3592NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33178203

GET https://conductscience.org/api/papers/v1/33178203/references?page=2